Atherosclerosis and Lipoproteins |
From the Institute of Medical Biochemistry and Medical Molecular Biology (V.S., S.F., A.H., W.F.G., G.M.K.), Karl-Franzens-University, Graz, Austria, and the Gaubius Laboratory (P.K., E.P., V.W.M.v.H.), TNO Prevention and Health, Leiden, The Netherlands.
Correspondence to Prof Dr Gerhard M. Kostner, Institute of Medical Biochemistry and Medical Molecular Biology, Harrachgasse 21/III, 8010 Graz, Austria. E-mail gerhard.kostner{at}kfunigraz.ac.at
AbstractAngiostatin,
which consists of the kringle IIV domains of plasminogen
and which is secreted into urine, is an efficient inhibitor
of angiogenesis and tumor growth. Because
N-terminal apolipoprotein(a)
[apo(a)] fragments, which also contain several types of kringle IV
domains, are found in urine as well, we evaluated the potential
angiostatic properties of these urinary apo(a) fragments and of a
recombinant form of apo(a) [r-apo(a)]. We used human microvascular
endothelial cell (hMVEC)based in vitro assays of tube
formation in 3-dimensional fibrin matrixes. Purified urinary apo(a)
fragments or r-apo(a) inhibited the basic fibroblast growth
factor/tumor necrosis factor-
induced formation of capillary-like
structures. At concentrations varying from 0.2 to 10 µg/mL, urinary
apo(a) fragments inhibited tube formation by as much as 70%, whereas
there was complete inhibition by r-apo(a). The highest concentrations
of both inhibitors also reduced urokinase
plasminogen activator production of
basic fibroblast growth factorinduced hMVEC proliferation. The
inhibitors had no effect on plasminogen
activator inhibitor-1 expression. If our in
vitro model for angiogenesis is valid for the in vivo situation as
well, our data point toward the possibility that apo(a) may also be
physiologically operative in modulating
angiogenesis, as the concentration of free apo(a) found in humans
exceeds that tested herein.
Key Words: Lp(a) endothelial cells kringle urinary fragments
This article has been cited by other articles:
![]() |
H.-K. Yu, J.-S. Kim, H.-J. Lee, J.-H. Ahn, S.-K. Lee, S.-W. Hong, and Y. Yoon Suppression of Colorectal Cancer Liver Metastasis and Extension of Survival by Expression of Apolipoprotein(a) Kringles Cancer Res., October 1, 2004; 64(19): 7092 - 7098. [Abstract] [Full Text] [PDF] |
||||
![]() |
J.-H. Ahn, J.-S. Kim, H.-K. Yu, H.-J. Lee, and Y. Yoon A Truncated Kringle Domain of Human Apolipoprotein(a) Inhibits the Activation of Extracellular Signal-regulated Kinase 1 and 2 through a Tyrosine Phosphatase-dependent Pathway J. Biol. Chem., May 21, 2004; 279(21): 21808 - 21814. [Abstract] [Full Text] [PDF] |
||||
![]() |
J.-S. Kim, J.-H. Chang, H.-K. Yu, J.-H. Ahn, J.-S. Yum, S.-K. Lee, K.-H. Jung, D.-H. Park, Y. Yoon, S.-M. Byun, et al. Inhibition of Angiogenesis and Angiogenesis-dependent Tumor Growth by the Cryptic Kringle Fragments of Human Apolipoprotein(a) J. Biol. Chem., August 1, 2003; 278(31): 29000 - 29008. [Abstract] [Full Text] [PDF] |
||||
![]() |
N. Busso, J. Dudler, R. Salvi, V. Peclat, V. Lenain, S. Marcovina, R. Darioli, P. Nicod, A. K. So, and V. Mooser Plasma Apolipoprotein(a) Co-Deposits with Fibrin in Inflammatory Arthritic Joints Am. J. Pathol., October 1, 2001; 159(4): 1445 - 1453. [Abstract] [Full Text] |
||||
|
ATVB Home | Subscriptions | Archives | Feedback | Authors | Help | AHA Journals Home | Search Copyright © 2001 American Heart Association, Inc. All rights reserved. Unauthorized use prohibited. |